MedTrace Logo

Retrospective Study in the Use of the Alfapump and the Treatment of Malignant Ascites

NCT03200106 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2018-04-09

No results posted yet for this study

Summary

Treatment of malignant ascites with the alfapump offers a new treatment option for this patient group. So far, there is no systematic analysis of patients with this indication available in the literature.

This retrospective analysis offers the possibility to assemble already existing data within a reasonably short time frame. Based on this analysis, a prospective analysis can be designed.

Conditions

  • Malignant Ascites

Interventions

DEVICE

Alfapump

Alfapump implant

Sponsors & Collaborators

  • Sequana Medical N.V.

    lead INDUSTRY

Principal Investigators

  • Jeroen Capel, MSc · Sequana Medical

  • Christina Fotopoulou, Ph.D · Hammersmith Hospitals NHS Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2018-02-28
Completion
2018-03-31

Countries

  • Germany
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03200106 on ClinicalTrials.gov